Yi-fan Wu
Nanjing, 210029, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Dual-utility ctDNA in diffuse large B-cell lymphoma: integrated genotyping unveils minimal residual disease dynamics and subtype-specific clonal evolution.
Journal: BMC medicine
Published: October 30, 2025
Penpulimab combined with rituximab, high-dose methotrexate, and cytarabine (Pen-RMA) in newly diagnosed primary central nervous system lymphoma (PCNSL): a phase 2 trial.
Journal: Blood cancer journal
Published: June 10, 2025
BTG1 Mutation Correlates with Inferior Prognosis in Diffuse Large B-Cell Lymphoma.
Journal: Cancer research and treatment
Published: May 08, 2025
PTPN2 Inhibition Disrupts Mitochondrial Renewal and Blocks TFRC-Mediated Mitophagy to Exert Anti-Tumor Activities in ALK-Positive Anaplastic Large Cell Lymphoma.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: November 04, 2024
Clinical implications of CSF-ctDNA positivity in newly diagnosed diffuse large B cell lymphoma.
Journal: Leukemia
Published: January 28, 2024
Identify truly high-risk TP53-mutated diffuse large B cell lymphoma patients and explore the underlying biological mechanisms.
Journal: Cell communication and signaling : CCS
Published: January 06, 2024
CD30 protects EBV-positive diffuse large B-cell lymphoma cells against mitochondrial dysfunction through BNIP3-mediated mitophagy.
Journal: Cancer letters
Published: September 08, 2023
Showing 1-8 of 8
Last Updated: 09/26/2026